CLINICAL_TRIALS
trial_result
· 2021-04-26
Clinical Trial Update: Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents [EARLY_Phase 1]
Summary
Early-phase trial assessing growth hormone to treat nonalcoholic fatty liver disease in adolescents has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: NAFLD | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-04-26